Company intelligence / Profile preview

Maxis AI

Edison, New Jersey, United Statesmaxisit.com ↗

Ownership: Private
Development stage: Commercial

Overview

Maxis AI delivers enterprise-grade artificial intelligence and analytics solutions to accelerate and optimize the management of clinical trial data. Their platform supports pharmaceutical and life sciences companies in achieving faster insights, improved data quality, regulatory compliance, and operational efficiency throughout the drug development lifecycle. The company’s technology has been validated in production environments with measurable improvements in trial oversight and decision-making

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

AWS (cloud hosting partnership)Partnerships with CROs for integrated solutions

Beyond the preview

Go deeper on Maxis AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maxis AI.

Explore the full profile